N. Wiedemann (1), C.G. Langdon (2), M.A. Held (2), J.T. Platt(2), F. Lévy (1), D. Robichon (1), C. Zanna (1), G. Vuagniaux (1), M. Sorensen (3), S. Wang (4), M.W. Bosenberg (2), D.F. Stern (2).
Presented at ELCC 2014, Geneva, Switzerland
(1) Debiopharm International SA, Switzerland
(2) Yale University, USA
(3) Ascenta Therapeutics, USA
(4) University of Michigan Cancer Center, USA